5 results match your criteria: "Affiliated to the University of Delhi[Affiliation]"

The increasing oxidative stress demands potential chemical compounds derived from natural resources with good antioxidant activity to overcome adverse health issues. In this context, we investigated the antioxidant properties of four dibenzopyrone phenolic compounds obtained from the endophytic fungus : altenusin, altenusin B, alterlactone, and dehydroaltenusin using DFT calculations. Our investigation focused on understanding the structure-antioxidant property relationship.

View Article and Find Full Text PDF

Systematic review: combination therapies for treatment-naïve chronic hepatitis B.

Aliment Pharmacol Ther

June 2008

Department of Gastroenterology, G.B. Pant Hospital, Affiliated to the University of Delhi, New Delhi, India.

Background: There is a renewed interest in use of combination therapies in treatment-naïve chronic hepatitis B (CHB) because of limitations of monotherapies.

Aim: To discuss the current status of combination therapies in treatment-naïve CHB.

Methods: PubMed search was done using 'combination', 'sequential' and 'chronic hepatitis B' as the search terms.

View Article and Find Full Text PDF

Aim: To assess the role of hepatitis B virus (HBV), hepatitis C virus (HCV) and alcohol intake as risk factors for hepatocellular carcinoma (HCC) in the presence or absence of cirrhosis in Indian population.

Methods: A total of 213 patients with HCC and 254 control subjects not affected with hepatic diseases or neoplasm were recruited. Odds ratios (ORs) were estimated for each risk factor and synergism among various risk factors was also studied.

View Article and Find Full Text PDF

Hepatitis C virus (HCV) genotypes help to tailor the treatment response, but their influence on the disease severity and association with hepatic steatosis is not well understood. The prevalence of HCV genotypes and their correlation with the histopathological severity of liver disease and steatosis in Indian patients were studied. HCV-RNA and genotyping was carried out in 398 patients with chronic hepatitis C.

View Article and Find Full Text PDF

Background: Monotherapy with interferon (IFN) or lamivudine is effective in a limited proportion of chronic hepatitis B (CHB) patients. A sequential combination may have better therapeutic effects by sustained viral suppression combined with immunomodulation.

Aim: To compare the efficacy of sequential lamivudine and IFN therapy versus lamivudine monotherapy in HBeAg positive CHB patients.

View Article and Find Full Text PDF